{"title":"[The Possibilities of Predicting Left Ventricular Ejection Fraction 12 Months After ST-Segment Elevation Myocardial Infarction].","authors":"A А Gurbanova, K G Pereverzeva, I E Tishkina","doi":"10.18087/cardio.2025.4.n2823","DOIUrl":null,"url":null,"abstract":"<p><p>Aim To identify predictors and develop a model for prognosis of left ventricular (LV) ejection fraction (EF) 12 months after ST-segment elevation myocardial infarction (STEMI) on electrocardiogram (ECG).Material and methods This was a prospective registry study of patients admitted within 24 h of STEMI. Concentrations of soluble suppression of tumorigenicity 2, proprotein convertase subtilisin/kexin type 9, N-terminal pro-B-type natriuretic peptide (NTproBNP), high-sensitivity troponin I (TnI), and C-reactive protein were measured. LVEF was determined using the Simpson method at one, 10-12 days, and 12 months after STEMI. The study included 138 patients; after 12 months, LVEF was determined in 112 patients. The patients were divided into groups based on their LVEF: with preserved EF (pLVEF), LVEF ≥50% (n=51); moderately reduced EF (mrLVFE), LVEF 41-49% (n=40); and reduced EF (rLVEF), LVEF ≤40% (n=11).Results A model for predicting LVEF 12 months after STEMI was constructed using the ordinal regression. The model sensitivity was 88.2% for predicting pLVEF, 71.8% for predicting mrLVEF, and 72.5% for predicting rLVEF. The model specificity was 59.1%. The factors determining LVEF in STEMI patients after 12 months included the formation of postinfarction LV aneurysm, LVEF on days 10-12 after STEMI, the magnitude in mm of ST segment elevation on the ECG upon admission, and the TnI concentration on the first day of STEMI.Conclusions The obtained model for predicting LVEF 12 months after STEMI allows prognosing LVEF in all its ranges with a sensitivity of more than 70%.</p>","PeriodicalId":54750,"journal":{"name":"Kardiologiya","volume":"65 4","pages":"52-56"},"PeriodicalIF":0.5000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kardiologiya","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18087/cardio.2025.4.n2823","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Aim To identify predictors and develop a model for prognosis of left ventricular (LV) ejection fraction (EF) 12 months after ST-segment elevation myocardial infarction (STEMI) on electrocardiogram (ECG).Material and methods This was a prospective registry study of patients admitted within 24 h of STEMI. Concentrations of soluble suppression of tumorigenicity 2, proprotein convertase subtilisin/kexin type 9, N-terminal pro-B-type natriuretic peptide (NTproBNP), high-sensitivity troponin I (TnI), and C-reactive protein were measured. LVEF was determined using the Simpson method at one, 10-12 days, and 12 months after STEMI. The study included 138 patients; after 12 months, LVEF was determined in 112 patients. The patients were divided into groups based on their LVEF: with preserved EF (pLVEF), LVEF ≥50% (n=51); moderately reduced EF (mrLVFE), LVEF 41-49% (n=40); and reduced EF (rLVEF), LVEF ≤40% (n=11).Results A model for predicting LVEF 12 months after STEMI was constructed using the ordinal regression. The model sensitivity was 88.2% for predicting pLVEF, 71.8% for predicting mrLVEF, and 72.5% for predicting rLVEF. The model specificity was 59.1%. The factors determining LVEF in STEMI patients after 12 months included the formation of postinfarction LV aneurysm, LVEF on days 10-12 after STEMI, the magnitude in mm of ST segment elevation on the ECG upon admission, and the TnI concentration on the first day of STEMI.Conclusions The obtained model for predicting LVEF 12 months after STEMI allows prognosing LVEF in all its ranges with a sensitivity of more than 70%.
期刊介绍:
“Kardiologiya” (Cardiology) is a monthly scientific, peer-reviewed journal committed to both basic cardiovascular medicine and practical aspects of cardiology.
As the leader in its field, “Kardiologiya” provides original coverage of recent progress in cardiovascular medicine. We publish state-of-the-art articles integrating clinical and research activities in the fields of basic cardiovascular science and clinical cardiology, with a focus on emerging issues in cardiovascular disease. Our target audience spans a diversity of health care professionals and medical researchers working in cardiovascular medicine and related fields.
The principal language of the Journal is Russian, an additional language – English (title, authors’ information, abstract, keywords).
“Kardiologiya” is a peer-reviewed scientific journal. All articles are reviewed by scientists, who gained high international prestige in cardiovascular science and clinical cardiology. The Journal is currently cited and indexed in major Abstracting & Indexing databases: Web of Science, Medline and Scopus.
The Journal''s primary objectives
Contribute to raising the professional level of medical researchers, physicians and academic teachers.
Present the results of current research and clinical observations, explore the effectiveness of drug and non-drug treatments of heart disease, inform about new diagnostic techniques; discuss current trends and new advancements in clinical cardiology, contribute to continuing medical education, inform readers about results of Russian and international scientific forums;
Further improve the general quality of reviewing and editing of manuscripts submitted for publication;
Provide the widest possible dissemination of the published articles, among the global scientific community;
Extend distribution and indexing of scientific publications in major Abstracting & Indexing databases.